Summary
Overview
Work History
Education
Skills
Websites
Certification
References
Publications
Timeline
Generic

Missy Hansen

Minneapolis,MN

Summary

Dynamic healthcare leader with extensive experience at ICON PLC, specializing in pediatric clinical research strategies across 80+ trials. Expertise in oncology and neuro-oncology, utilizing critical thinking and cross-functional collaboration to enhance patient care and operational efficiency. Developed innovative tools such as the Pediatric Risk Assessment Map to mitigate trial risks and improve outcomes. Aiming to leverage this expertise to further advance clinical research methodologies and patient-centric solutions.

Overview

31
31
years of professional experience
1
1
Certification

Work History

Associate Director for Therapeutic Expertise, Pediatric Strategy Liaison

ICON PLC
12.2019 - 03.2025
  • Represented the Center for Pediatric Clinical Development with clients and other key stakeholders dedicated to pediatric clinical research
  • Substantially contributed strategy and operational expertise to 80+ trials for 50+ biotech and pharma sponsors
  • Early engagement with stakeholders reviewing pipeline and targeted indications providing therapeutic and treatment landscape feedback
  • Operational support from strategy through trial conduct
  • Primary pediatric subject matter expert working with Business Development
  • Provided knowledge and support to internal and external clients developing global therapeutic product strategies for multiple therapeutic areas in the pediatric population
  • Expertise and focus on oncology, neuro-oncology, malignant and non-malignant hematology studies
  • Input on clinical trial design including selection criteria, length of study, cohorts, schedule of assessments, patient and family value add for enrolment, placebo and standard of care arms
  • Worked in cooperation with clients and Icon team to ensure the appropriate strategies are employed to successfully conduct clinical trials with pediatric patients including patient, site, provider facing materials input; informed consent form review, region and site considerations, comfort and support items
  • Lead on the development and updating of the Pediatric Risk Assessment Map (PRAM), a first in class tool to help stakeholders of pediatric protocol development plan, identify and reduce risk inherent in any stage of clinical trial development
  • Development of internal and external stakeholder recruitment and retention strategy supporting the unique needs of the adolescent and young adult (AYA) patient in cancer clinical trials
  • Stays abreast of key regulations and developments that impact pediatric clinical development, Icon contact for Research to Accelerate Cures and Equity (RACE) Act review

Certified Pediatric Nurse Practitioner

Children’s Minnesota
12.2007 - 12.2019
  • Provided advanced practice clinical care of pediatric and AYA patients diagnosed with cancers and blood disorders including health assessments, formulated and assessed plans of care, education and support to patient and family, coordinated care services, performed consults, ordered and interpreted labs and diagnostic tests, ordered and performed diagnostic and evaluative procedures such as lumbar punctures and bone marrow aspirations/biopsies, provided after hour on call expertise as required
  • Primary patient population neuro-oncology
  • Cancer and Blood Disorders Clinic Lead NP 2016-2019
  • Preceptor for nurse practitioner students
  • Developed post-operative brain tumor pathway to educate bedside nurses and other staff on current best practices for care of the patient
  • Built and maintained exemplary relationships with radiation centers to provide seamless transition of care
  • Developed patient care and workflow improvements for newly initiated (2018) onsite 24-hour inpatient care model
  • Involved in Leukemia and Lymphoma Society Back to School outreach program
  • Educate school personal and family on oncology diagnoses, therapies and school related special needs

Certified Pediatric Nurse Practitioner

Eagan Valley Pediatrics, MN
06.2004 - 11.2007
  • Provided advance practice clinical care for pediatric patients for well child, minor trauma, acute and chronic illnesses, health maintenance and health promotion

Certified Pediatric Nurse Practitioner

Children's MN
03.2002 - 05.2004
  • Provided advanced practice clinical care of infant, pediatric and young adult patients diagnosed with cancers and blood disorders

Certified Pediatric Nurse Practitioner

Pediatric and Adolescent Care Clinic (PACE), MN
02.1994 - 12.2001
  • Provided advance practice clinical care for pediatric patients for well child, minor trauma, acute and chronic illnesses, health maintenance and health promotion

Education

MASTER OF SCIENCE - NURSING, Pediatric Nurse Practitioner Focus

University of Minnesota
MN
09.1993

BACHELOR OF SCIENCE - NURSING

St. Catherine University
St. Paul, MN
05.1989

Skills

  • Critical Thinking
  • Process improvement
  • Cross-Functional Collaboration
  • Detail-Oriented Approach
  • Comprehensive Patient Care

Certification

  • Certified Pediatric Nurse Practitioner, Pediatric Nursing Certification Board, 12/01/93, ongoing
  • Registered Nurse, MN Board of Nursing, 08/01/89, ongoing

References

  • Mark Sorrentino, MS MD, Vice President, Center for Pediatric Clinical Development at Icon Plc, sorrentinom@me.com or mark.sorrentino@iconplc.com
  • Jacqui Whiteway, PhD, Sr. Director, Pediatric Strategy Liaison at Icon Plc, whitewayjacqueline@gmail.com or jacqueline.whiteway@iconplc.com
  • Kelli Wright, Director, Patient Advocacy, Day One Biopharmaceuticals, kelli.wright@dayonebio.com
  • Diana Osorio, MD, MPH, Associate Professor/Neuro-Oncology MD Anderson, DSOsorio@mdanderson.org

Publications

  • The RACE for Children Act prompts more pediatric clinical trials for oncology drug developers, Melissa Hansen, MSN, APRN, CNP, KoNECT, 2023
  • RACE Act Prompts More Pediatric Clinical Trials for Oncology Drug Developers, Missy Hansen, Assoc. of Pediatric Hematology and Oncology Nurses (APHON) Annual Conference, 2022
  • Cerebellar Mutism Syndrome in Children After Surgery for a Posterior fossa Tumor: Patient Characteristics and Recovery, Melissa Hansen, MSN, APRN, CNP; Anne Bendel, MD; et al, Journal of Pediatric Hematology Oncology Nursing, 2022, Vol. 39(4) 243-249, 2022
  • Adolescents in Clinical Trials and the RACE for Children Act, Missy Hansen, MSN, CPNP; Lori Ranney, DNP, CPNP, Webinar, 2021
  • Re-evaluating Pediatric Cancer Endpoints, Melissa Hansen CPNP, Harris Dalrymple, PhD; Joanna Perkins, MD, White Paper, 2021
  • RACE Act Prompts More Pediatric Clinical Trials for Oncology Drug Developers, Melissa Hansen, Harris Dalrymple, White Paper, 2020
  • Global Pediatric Drug Development Collaboration: Part One, Dr. Martine Dehlinger-Kremer; Jo Dewhurst, BSc, (Hons), LLB Dip; Melissa Hansen, CPNP; Jacqui Whiteway, PhD, White Paper, 2020
  • Global Pediatric Drug Development Collaboration: Part Two, Dr. Martine Dehlinger-Kremer; Jo Dewhurst, BSc, (Hons), LLB Dip; Melissa Hansen, CPNP; Jacqui Whiteway, PhD, White Paper, 2020
  • Effects of proactive and rescue enteral tube feedings on weight change in children undergoing treatment for high-grade central nervous system tumors, Charles R. Bendelsmith, BS, Amy M Linabery, PhD, MS, Amanda J Nickel, MPH, Rachel M Laquere, RDN, LD, Katherine M Ingram, PhD, Melissa B Hansen, APRN, CNP, Julie A Pape-Blabolil, APRN, CNP, Mary M Skrypek, MD, Anne E Bendel, MD, Neuro-Oncology, npaa003, https://doi.org/10.1093/nop/npaa003
  • The RACE for Children Act: How Industry Can Accelerate Readiness Through Collaboration with Patient Organizations, Missy Hansen, CPNP; Laura Iliescu; Kendall JamesDavis, MPH; Caitlyn Barrett, PhD; Kelli Wright; Jacqueline Whiteway, PhD, White Paper, 2020
  • The RACE for Children Act: Collaborating for Success, Missy Hansen, MSN, APRN, CPNP; Joanna Perkins, MD, MS; Gwen Nichols, MD, CMO; E. Anders (Andy) Kolb, MD, Director, Webinar, 2020
  • PRA: Get Ready for the RACE Act, Missy Hansen, CPNP; Mark Sorrentino, MD; Martine Dehlinger-Kremer, PhD; Jacqui Whiteway, PhD, Article, 2020
  • International Clinical Trials: Surviving Isn’t Thriving, Missy Hansen, CPNP; Jacqui Whiteway, PhD, Article, 2020
  • Evaluation of Proactive and Rescue Enteral Tube Feedings in Children Undergoing Treatment for Medulloblastoma and Supratentorial PNET, A Single institution retrospective Chart Review., Bendel, A., Laquere, R., Ingram, K.l, Hansen, M., Pape-Blabolil, J., Skrypek, M., Bendelsmith, C., Neuro-Oncology, Volume 19 (suppl-6):vi169, 11/01/17
  • MB-73 Case Report: Multiple Pilomatrixomas in a Survivor of WNT+ Medulloblastoma Leading to the Discovery of a Germline APC Mutation and the Diagnosis of Familial Adenomatosis Polyposis., Bendel, A., Skrypek, M., Hansen, M., Wein, A., Nagib, M., McDonald, W., Pond, D., Neuro-Oncology, Volume 18 (suppl_3):iii113, 2016
  • Case Report of an Optic Pathway Glioma in a Patient with Legius Syndrome, Skrypek, M., Bendel, A., Kebriaei, M., Mendelsohn, N., Wein, A., Hansen, M., Siqveland, E., Listernick, R., Neuro-Oncology, Volume 18 (suppl_3):iii91, 06/01/16

Timeline

Associate Director for Therapeutic Expertise, Pediatric Strategy Liaison

ICON PLC
12.2019 - 03.2025

Certified Pediatric Nurse Practitioner

Children’s Minnesota
12.2007 - 12.2019

Certified Pediatric Nurse Practitioner

Eagan Valley Pediatrics, MN
06.2004 - 11.2007

Certified Pediatric Nurse Practitioner

Children's MN
03.2002 - 05.2004

Certified Pediatric Nurse Practitioner

Pediatric and Adolescent Care Clinic (PACE), MN
02.1994 - 12.2001

MASTER OF SCIENCE - NURSING, Pediatric Nurse Practitioner Focus

University of Minnesota

BACHELOR OF SCIENCE - NURSING

St. Catherine University

Similar Profiles

CREATE PROFILE
Missy Hansen